These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30228597)

  • 1. Prescription Drug Monitoring Program: Useful Tool or Government Control?
    Lilly JD
    Mo Med; 2017; 114(4):234-236. PubMed ID: 30228597
    [No Abstract]   [Full Text] [Related]  

  • 2. The Case for a PDMP in Missouri.
    Page SL
    Mo Med; 2017; 114(4):231-233. PubMed ID: 30228596
    [No Abstract]   [Full Text] [Related]  

  • 3. Access to opioids: a balance of harms.
    The Lancet Oncology
    Lancet Oncol; 2017 Oct; 18(10):1285. PubMed ID: 28971809
    [No Abstract]   [Full Text] [Related]  

  • 4. Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages.
    Haffajee RL; Mello MM; Zhang F; Zaslavsky AM; Larochelle MR; Wharam JF
    Health Aff (Millwood); 2018 Jun; 37(6):964-974. PubMed ID: 29863921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription Opioid Misuse and Overuse in the U.S.
    Fleming DA
    Mo Med; 2018; 115(3):189-190. PubMed ID: 30228715
    [No Abstract]   [Full Text] [Related]  

  • 6. From Dark Dens to Suburban Townhouses: Creating a Centralized System for Prescription Opiate Monitoring to Combat the Addiction Epidemic in the United States.
    Mitchell CA
    J Leg Med; 2018; 38(1):119-162. PubMed ID: 29697320
    [No Abstract]   [Full Text] [Related]  

  • 7. Despite Distractions, Legislators Look to Address Opioid Crisis.
    Patterson J
    Mo Med; 2018; 115(6):499-500. PubMed ID: 30643329
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the Hydrocodone Schedule Change on Opioid Prescription Patterns in South Dakota.
    Kuschel LM; Mort JM
    S D Med; 2017 Oct; 70(10):449-455. PubMed ID: 28957619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can prescription drug monitoring programs help limit opioid abuse?
    Gugelmann HM; Perrone J
    JAMA; 2011 Nov; 306(20):2258-9. PubMed ID: 22110107
    [No Abstract]   [Full Text] [Related]  

  • 10. County-Level Opioid Prescribing in the United States, 2015 and 2017.
    Guy GP; Zhang K; Schieber LZ; Young R; Dowell D
    JAMA Intern Med; 2019 Apr; 179(4):574-576. PubMed ID: 30742206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing claims for prescription drugs with a high potential for abuse.
    Hoffman L; Enders JL; Pippins J; Segal R
    Am J Health Syst Pharm; 2003 Feb; 60(4):371-4. PubMed ID: 12625220
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
    Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
    J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.
    Barnett ML; Gray J; Zink A; Jena AB
    N Engl J Med; 2017 Dec; 377(24):2306-2309. PubMed ID: 29236636
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
    Phillips E; Gazmararian J
    J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
    Yarbrough CR
    Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Prescriptions by Specialty in Ohio, 2010-2014.
    Weiner SG; Baker O; Rodgers AF; Garner C; Nelson LS; Kreiner PW; Schuur JD
    Pain Med; 2018 May; 19(5):978-989. PubMed ID: 28339965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcotic pain relievers: are you using them correctly?
    Johns Hopkins Med Lett Health After 50; 2012 Nov; 24(10):1-2. PubMed ID: 23362527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.